Even though most of U.S.-based cannabis organizations and several foreign American Depository Receipts (ADRs) trade throughout the countertop (OTC), a couple of marijuana businesses are exchanged in the NASDAQ. Some investors choose shares which are noted on the NASDAQ with other exchanges because of the increased liquidity and tighter spreads set alongside the markets that are over-the-counter. For instance, given that cannabis industry has exploded in present months and years, uplisting from an OTC market to a reputable U.S. trade is actually an advertising achievement for all marijuana that is rising. (For related reading, see “Understanding healthcare Cannabis vs. Recreational Cannabis shares”)
An increasing amount of marijuana organizations are being noted on reputable U.S. exchanges instead of being exchanged in the OTC market showing the fast growth of the cannabis industry.
NASDAQ-listed Marijuana shares
The NASDAQ had been the very first electronic trade and is definitely synonymous with technology and biotechnology. The cannabis businesses in the NASDAQ reflect this, plus the almost all them operate in the biotech area of this industry. Here you will find the marijuana that is NASDAQ-listed, in alphabetical purchase, at the time of October 26, 2019, with a dysfunction of these total returns.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Arena Pharmaceuticals is really a biotech business involved in the production of medical marijuana medications. Research and development around Arena’s APD371 may canabis oil be the main focus for the company’s cannabis biotech initiatives.
Atlantic Alliance Partnership Corp. (NASDAQ:AAPC)
Atlantic Alliance Partnership Corp. is really a check that is blank that is currently in a merger contract with Kalyx Development Inc. Kalyx is a number one investment rely upon the regulated cannabis industry in america.
- The cannabis industry, specially the part of cannabis and biotech, is attracting investor attention that is substantial.
- Cannabis will be utilized in brand new drugs for the treating pain and chronic that is many inflammatory, and fibrotic conditions.
- Organizations may also be developing cannabinoid services and products for autism spectrum problems, schizophrenia, glioma, Tourette problem, epileptic problems, Prader-Willi Syndrome (an inherited condition), and amphetamine addiction.
Cara Therapeutics Inc. (NASDAQ:CARA)
Cara Therapeutics is really a clinical-stage biotechnology company focused on developing and commercializing new chemical entities when it comes to indications of discomfort and pruritus (itching). Although all the firm’s clinical-stage items target opioid receptors, Cara is currently conducting preclinical research on cannabinoids to treat neuropathic discomfort.
Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)
Corbus Pharmaceuticals Holdings Inc. is really a cannabis biotech company. The team’s research, development, and production are based around cannabis drugs that look for to take care of chronic, inflammatory, fibrotic, along with other conditions.
Cronos Group Inc. (NASDAQ:CRON)
Cronos Group Inc. is just A canadian cannabis business. The team has and seeks cannabis-related subsidiaries and licensed manufacturers. In December of 2018, Marlboro maker Altria announced intends to spend $1.8 billion in Cronos. The investment has provided Cronos not just with additional money to invest in its continued expansion but additionally with a well-established partner experienced within the advertising of customer brands.
Greenlane Holdings Inc. (NASDAQ:GNLN)
Greenlane Holdings Inc. is really a Boca Raton, Florida-based cannabis business. It distributes a number of cannabis usage accessories and vaporization gear and products to retail clients in the U.S. and Canada. Furthermore, it runs e-commerce internet sites for extra product sales.
GW Pharmaceuticals Plc. (NASDAQ:GWPH)
GW Pharmaceuticals is creating a portfolio of cannabinoid medications. These medicines consist of Sativex to treat spasticity associated with sclerosis that is multiple cancer tumors pain and Epidiolex for the treatment of childhood epilepsy. Sativex is commercialized much more than a dozen nations outside of the United States and contains gotten approval that is regulatory some other nations. Epidiolex received Food And Drug Administration approval as being a therapy for Dravet Syndrome and Lennox-Gastaut Syndrome, two kinds of serious, very very early beginning epilepsy without good current treatment plans. Other indications reveal that GW Pharmaceuticals is developing products that are cannabinoid autism range problems, schizophrenia, and glioma.
Intec Pharma Ltd. (NASDAQ:NTEC)
Intec Pharma is just a clinical-stage biopharmaceutical business that is developing drugs centered on its proprietary Accordion Pill technology. Intec’s item pipeline includes cannabinoid-based medications for lower pain that is back fibromyalgia.
Marrone Bio Innovations, Inc. (NASDAQ:MBII)
Marrone Bio Innovations, Inc. develops and distributes environmentally accountable bio-based pest management and plant wellness items. In 2017, Marrone Bio Innovations announced that three MBII active ingredients are now legal to be used on cannabis crops into the Ca cultivation market.
Modern Beverages Corp. (NASDAQ:NBEV)
Modern Beverages Corp. is really a maker of beverages produced from yerba mate, green tea leaf, kombucha, and comparable services and products. In recent months, modern age has expanded its beverage offerings to incorporate CBD infusions too, bringing it in to the orbit of cannabis stocks.
OrganiGram Holdings Inc. (NASDAQ:OGI)
Canadian cannabis producer OrganiGram Holdings Inc. debuted from the NASDAQ in might of 2019, which makes it one of the more present cannabis organizations to record from the exchange that is popular. The business was quickly expanding its manufacturing ability that can have the ability to create up to 113,000 kilograms of product per by the end of 2019 year.
Psychemedics Corporation (NASDAQ:PMD)
Psychemedics Corporation runs into the enforcement sector. The business’s business operations support medication evaluation through hair samples.
Sundial Growers Inc. (NASDAQ:SNDL)
Alberta, Canada-based Sundial Growers Inc. is another entry that is new the NASDAQ trade. The cannabis producer made headlines in October of 2019 (and saw a price that is brief) whenever it announced the production of a brand new Palmetto make of recreational cannabis, first for sale in Saskatchewan and Manitoba.
Therapix Biosciences Ltd. (NASDAQ:TRPX)
Therapix Biosciences Ltd. is really a specialty clinical-stage company that is pharmaceutical regarding the growth of cannabinoid-based medications. Therapix’s present pipeline includes items targeted for the treatment of Tourette problem and mild impairment that is cognitive.
Tilray Inc. (NASDAQ:TLRY)
Tilray Inc. ended up being initial marijuana-related company to have a preliminary general public providing (IPO) in america. The Nanaimo, Vancouver Island-based company concentrates on medical cannabis items.
Village Farms Global (NASDAQ:VFF)
Village Farms Global is considered the most current cannabis stock to begin investing on the NASDAQ. The business’s stocks became designed for trade on February 21, 2019. The organization possesses history that is decades-long greenhouse produce production and contains only recently shifted a number of its focus toward cannabis manufacturing.
Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)
Zynerba Pharmaceuticals is targeted in the development of artificial treatments that are cannabinoid transdermal (through skin) delivery. Their pipeline currently includes two medications being developed for indications including epilepsy, osteoarthritis, fibromyalgia, peripheral neuropathic discomfort, and delicate X syndrome.